BioMarin's dwarfism therapy gets FDA nod for expanded use

Submitted by admin on October 23, 2023 - 9:08am

Source:

Reuters

News Tags:

BioMarin Pharmaceutical

short-limbed dwarfism

FDA

Voxzogo

Headline:

BioMarin's dwarfism therapy gets FDA nod for expanded use

snippet:

The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's (BMRN.O) once-daily injection to treat children under the age of 5 with the most common form of short-limbed dwarfism.

Search form

You are here

BioMarin's dwarfism therapy gets FDA nod for expanded use

BioMarin's dwarfism therapy gets FDA nod for expanded use